Aligos Therapeutics


Aligos Therapeutics is discovering and developing new classes of compounds that interact directly with disease causing molecules.

Industries

Employees

51-200

Links


Org chart

Lawrence M. Blatt
Chairman & CEO
Collapse
Lucinda Y. Quan
EVP, Chief Business Officer & General Counsel
Julian A. Symons
EVP & Chief Scientific Officer
Dave Smith
Executive Vice President
Kha le
Executive Director

Board & advisors

Jack B. Nielsen
Lead Independent Director